Evidence map›Paper›PMID 41378079›Full record

ReviewWorld journal of gastrointestinal pharmacology and therapeutics2025

Harnessing postbiotics for liver health: Emerging perspectives.

Naveen Jeyaraman, Madhan Jeyaraman, Tejaswin Mariappan, Arulkumar Nallakumarasamy, Preethi Subramanian, Priyadarshini T, Vinnisa Nithiakala Vetrivel

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal pharmacology and therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Naveen JeyaramanDepartment of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India.
Madhan JeyaramanDepartment of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India.
Tejaswin MariappanDepartment of Community Medicine, Government Stanley Medical College and Hospital, Chennai 600001, Tamil Nadu, India.
Arulkumar NallakumarasamyDepartment of Regenerative Medicine, Agathisha Institute of Stemcell and Regenerative Medicine, Chennai 600030, Tamil Nadu, India.
Preethi SubramanianDepartment of Radiation Oncology, Apollo Proton Cancer Centre, Chennai 600113, Tamil Nadu, India.
Priyadarshini TDepartment of Anaesthesiology, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India.
Vinnisa Nithiakala VetrivelDepartment of Obstetrics and Gynecology, Vinayaka Mission Medical College and Hospital, Karaikal 609609, Puducherry, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With emerging scientific breakthroughs, it has been established that gut microbiome dysbiosis has an undeniable correlation with hepatic diseases through complex interlinked metabolic pathways. There's always been a need for new therapeutic options to deal with the rising prevalence of metabolic dysfunction-associated steatotic liver disease, liver cirrhosis, alcoholic liver disease, hepatocellular carcinoma

Indexed as

Gut dysbiosisLiverPostbioticsPrebioticsProbioticsShort chain fatty acids

Identifiers

PMID41378079
PMCPMC12687020

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.